default search action
"Toxicity risks evaluation of unknown FDA biotransformed drugs based on a ..."
Mohamed Abd El Aziz et al. (2020)
- Mohamed Abd El Aziz, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong:
Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach. Appl. Soft Comput. 97(Part B): 105509 (2020)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.